CA
NZ
UK
AU
IND
US
…
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Income before tax | 442.00M | 1521.00M | 1339.00M | 1504.00M | 1360.00M |
| Net income | 434.00M | 1289.00M | 1240.00M | 1254.00M | 1210.00M |
| Selling general administrative | - | 1469.00M | - | - | 1619.00M |
| Selling and marketing expenses | - | 49.00M | - | - | - |
| Gross profit | 990.00M | 3559.00M | 3465.00M | 3722.00M | 3407.00M |
| Ebit | 443.00M | 1617.00M | 1350.00M | 1677.00M | 1404.00M |
| Ebitda | 731.00M | 1874.00M | 1621.00M | 1994.00M | 1725.00M |
| Depreciation and amortization | 288.00M | 257.00M | 271.00M | 317.00M | 321.00M |
| Operating income | 443.00M | 1593.00M | 1350.00M | 1677.00M | 1404.00M |
| Other operating expenses | 1418.00M | 4917.00M | 5450.00M | 5269.00M | 4880.00M |
| Interest expense | 27.00M | 96.00M | - | - | 0.00M |
| Tax provision | - | - | - | - | 150.00M |
| Interest income | - | - | - | - | 79.00M |
| Income tax expense | 8.00M | 232.00M | 99.00M | 250.00M | 150.00M |
| Total revenue | 1861.00M | 6510.00M | 6833.00M | 6848.00M | 6319.00M |
| Total operating expenses | 547.00M | 1966.00M | 2082.00M | 2143.00M | 1968.00M |
| Cost of revenue | 871.00M | 2951.00M | 3368.00M | 3126.00M | 2912.00M |
| Total other income expense net | -1.00M | -72.00M | -11.00M | -173.00M | -44.00M |
| Net income applicable to common shares | - | - | - | 1254.00M | 1210.00M |
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Total assets | 12727.00M | 11931.00M | 10763.00M | 10532.00M | 10705.00M |
| Intangible assets | 445.00M | 547.00M | 475.00M | 821.00M | 981.00M |
| Other current assets | 293.00M | 187.00M | 274.00M | 282.00M | 222.00M |
| Total liab | 5986.00M | 6033.00M | 4918.00M | 5227.00M | 5316.00M |
| Total stockholder equity | 6741.00M | 5898.00M | 5845.00M | 5305.00M | 5389.00M |
| Other current liab | 805.00M | 682.00M | 1185.00M | 1281.00M | 1262.00M |
| Common stock | 3.00M | 3.00M | 3.00M | 3.00M | 3.00M |
| Retained earnings | 1389.00M | 750.00M | 782.00M | 324.00M | 348.00M |
| Other liab | - | - | - | 633.00M | 749.00M |
| Good will | 4473.00M | 4477.00M | 3960.00M | 3952.00M | 3975.00M |
| Other assets | - | - | 708.00M | 536.00M | 642.00M |
| Cash | 1789.00M | 1329.00M | 1590.00M | 1053.00M | 1484.00M |
| Total current liabilities | 2347.00M | 1895.00M | 1603.00M | 1861.00M | 1708.00M |
| Current deferred revenue | 624.00M | 544.00M | - | - | - |
| Net debt | 1899.00M | 2287.00M | -1590.00M | -1053.00M | -1484.00M |
| Short term debt | 348.00M | 129.00M | - | - | - |
| Short long term debt total | 3688.00M | 3616.00M | - | - | 2729.00M |
| Other stockholder equity | 5575.00M | 5450.00M | 5060.00M | 4978.00M | 5038.00M |
| Property plant equipment | - | - | - | 1100.00M | 1123.00M |
| Total current assets | 4594.00M | 3959.00M | 4186.00M | 3778.00M | 3799.00M |
| Net tangible assets | - | - | - | 516.00M | 433.00M |
| Short term investments | - | - | - | - | 91.00M |
| Net receivables | 1487.00M | 1471.00M | 1291.00M | 1405.00M | 1172.00M |
| Long term debt | - | - | - | - | 2729.00M |
| Inventory | 1025.00M | 972.00M | 1031.00M | 1038.00M | 830.00M |
| Accounts payable | 570.00M | 540.00M | 418.00M | 580.00M | 446.00M |
| Accumulated other comprehensive income | -226.00M | -305.00M | - | - | - |
| Non currrent assets other | 1059.00M | 376.00M | -5869.00M | -6218.00M | -6264.00M |
| Non current assets total | 8133.00M | 7972.00M | 5869.00M | 6218.00M | 6264.00M |
| Breakdown | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-10-31 | 2024-10-31 | 2023-10-31 | 2022-10-31 | 2021-10-31 |
| Investments | - | - | - | 9.00M | -10.00M |
| Change to liabilities | - | - | - | 121.00M | 64.00M |
| Total cashflows from investing activities | -394.00M | -1258.00M | - | -338.00M | -749.00M |
| Net borrowings | - | - | - | 26.00M | 356.00M |
| Total cash from financing activities | -715.00M | -752.00M | -930.00M | -1372.00M | -696.00M |
| Change to operating activities | - | - | - | -30.00M | 98.00M |
| Net income | 434.00M | 1289.00M | 1240.00M | 1254.00M | 1210.00M |
| Change in cash | 459.00M | -261.00M | 537.00M | -434.00M | 43.00M |
| Begin period cash flow | 1332.00M | 1590.00M | 1056.00M | 1490.00M | 1447.00M |
| End period cash flow | 1791.00M | 1329.00M | 1593.00M | 1056.00M | 1490.00M |
| Total cash from operating activities | 1559.00M | 1751.00M | 1772.00M | 1312.00M | 1485.00M |
| Depreciation | 288.00M | 257.00M | 271.00M | 317.00M | 321.00M |
| Other cashflows from investing activities | -406.00M | -13.00M | - | -4.00M | -5.00M |
| Dividends paid | 282.00M | 274.00M | 265.00M | 250.00M | 236.00M |
| Change to inventory | 45.00M | 34.00M | -33.00M | -248.00M | -136.00M |
| Change to account receivables | -149.00M | 7.00M | 132.00M | -321.00M | -128.00M |
| Sale purchase of stock | -425.00M | -1153.00M | -629.00M | -1206.00M | -864.00M |
| Other cashflows from financing activities | -39.00M | -30.00M | -36.00M | 693.00M | 821.00M |
| Change to netincome | - | - | - | 219.00M | 56.00M |
| Capital expenditures | 407.00M | 378.00M | 298.00M | 291.00M | 188.00M |
| Change in working capital | -58.00M | 83.00M | 99.00M | -569.00M | -264.00M |
| Stock based compensation | 128.00M | - | 111.00M | 126.00M | 111.00M |
| Other non cash items | 897.00M | 186.00M | 51.00M | 184.00M | 107.00M |
| Free cash flow | 1152.00M | 1373.00M | 1474.00M | 1021.00M | 1297.00M |
|
Stock Name
|
Change
(GBX) |
Price
(GBX) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
|---|---|---|---|---|---|---|
| 0HAV Agilent Technologies Inc. |
2.49 1.42% |
177.80 | 0.28 | - | 5.16 | - |
| 0R15 SoftBank Group Corp. |
248.00 5.84% |
4494.00 | - | - | - | - |
| 0R1E Nintendo Co. Ltd. |
-115.00 1.34% |
8476.00 | - | - | - | - |
| 0LC3 Synchrony Financial |
2.34 3.20% |
75.60 | 0.09 | - | 4.97 | - |
| 0HQP CBRE Group Inc. Cl A |
0.15 0.12% |
122.47 | 0.25 | - | 1.18 | - |
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.
5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051
800 227 9770
18000
| Name | Title | Year Born |
|---|---|---|
| Mr. Michael R. McMullen | CEO, Pres & Director | 1961 |
| Mr. Robert W. McMahon | Sr. VP & CFO | 1969 |
| Mr. Jacob Thaysen | Sr. VP and Pres of Life Sciences & Applied Markets Group | 1975 |
| Mr. Samraat S. Raha | Sr. VP and Pres of Diagnostics & Genomics Group | 1973 |
| Mr. Padraig McDonnell | Sr. VP & Pres of Agilent Cross Lab Group | NA |
| Mr. Rodney Gonsalves | Principal Accounting Officer, VP & Corp. Controller | 1966 |
| Dr. Darlene J. S. Solomon Ph.D. | CTO & Sr. VP | 1959 |
| Mr. Michael Tang | Sr. VP, Gen. Counsel & Sec. | 1974 |
| Mr. Dominique P. Grau | Sr. VP of HR & Global Communications | 1959 |
| Ms. Allison Ballmer | Sr. VP of Strategy & Corp. Devel. | NA |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
+0.40%
Communication Services
-0.27%
Consumer Cyclical
-0.12%
Consumer Defensive
-0.30%
Energy
+0.37%
Financial Services
-0.36%
Financials
+0.75%
Healthcare
+0.84%
Industrials
+0.28%
Real Estate
-0.34%
Technology
+1.20%
Utilities
+0.17%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...